Suppr超能文献

经巩膜局部切除术后葡萄膜黑色素瘤残留和复发的危险因素。

Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

作者信息

Damato B E, Paul J, Foulds W S

机构信息

Tennent Institute of Ophthalmology, Western Infirmary, University of Glasgow.

出版信息

Br J Ophthalmol. 1996 Feb;80(2):102-8. doi: 10.1136/bjo.80.2.102.

Abstract

AIMS

The aims of this study were to report local tumour control after trans-scleral local resection of uveal melanoma and to identify risk factors for (i) clinical residual tumour recognised immediately after surgery, and (ii) delayed tumour recurrence from subclinical microscopic deposits.

METHODS

The sample included 310 patients, treated by choroidectomy (188), cyclochoroidectomy (87), or iridocyclectomy (35), with follow up ranging from 42 days to 20.9 years (median 36 months), a mean basal largest tumour diameter of 13.2 mm, and a mean tumour thickness of 7.4 mm.

RESULTS

There were 24 patients with residual tumour. Forward stepwise logistic regression indicated that posterior extension to within 1 disc diameter of the optic disc or fovea was the sole best indicator of the risk of residual disease (p < 0.001). After excluding these cases, 286 patients were studied for the development of delayed local recurrence, which occurred in 57 cases. Forward stepwise multivariate analysis showed the statistically significant predictors for recurrent tumour to be epithelioid cellularity (p = 0.002), posterior tumour extension to < 1 disc diameter of disc of fovea (p = 0.002), large tumour diameter > or = 16 mm (p = 0.019) and lack of adjunctive plaque radiotherapy (p = 0.018).

CONCLUSIONS

The recurrence rate at 4 years varied from 6% if no risk factors were present to 57% if there were more than two risk factors.

摘要

目的

本研究旨在报告经巩膜局部切除葡萄膜黑色素瘤后的局部肿瘤控制情况,并确定(i)手术后立即识别出的临床残留肿瘤,以及(ii)亚临床微小病灶导致的延迟肿瘤复发的危险因素。

方法

样本包括310例患者,接受脉络膜切除术(188例)、睫状体脉络膜切除术(87例)或虹膜睫状体切除术(35例),随访时间从42天至20.9年(中位时间36个月),平均基底最大肿瘤直径为13.2 mm,平均肿瘤厚度为7.4 mm。

结果

有24例患者存在残留肿瘤。向前逐步逻辑回归表明,肿瘤向后延伸至距视盘或黄斑中心凹1个视盘直径范围内是残留疾病风险的唯一最佳指标(p < 0.001)。排除这些病例后,对286例患者进行了延迟局部复发情况的研究,其中57例发生了延迟局部复发。向前逐步多变量分析显示,复发性肿瘤的统计学显著预测因素为上皮样细胞成分(p = 0.002)、肿瘤向后延伸至距视盘或黄斑中心凹< 1个视盘直径(p = 0.002)、肿瘤直径≥16 mm(p = 0.019)以及未进行辅助斑块放射治疗(p = 0.018)。

结论

4年复发率在无危险因素时为6%,有两个以上危险因素时为57%。

相似文献

3
Local resection of uveal melanoma.葡萄膜黑色素瘤的局部切除术。
Dev Ophthalmol. 2012;49:66-80. doi: 10.1159/000328261. Epub 2011 Oct 21.
6
Endoresection of choroidal melanoma.脉络膜黑色素瘤的内切除术。
Br J Ophthalmol. 1998 Mar;82(3):213-8. doi: 10.1136/bjo.82.3.213.
8
Uveal tumour resection.葡萄膜肿瘤切除术。
Br J Ophthalmol. 2001 Oct;85(10):1213-9. doi: 10.1136/bjo.85.10.1213.

引用本文的文献

5
Recurrent melanoma arising from sclera.起源于巩膜的复发性黑色素瘤。
Am J Ophthalmol Case Rep. 2022 May 5;27:101562. doi: 10.1016/j.ajoc.2022.101562. eCollection 2022 Sep.
6
Surgical Approach in Intraocular Tumors.眼内肿瘤的手术入路。
Turk J Ophthalmol. 2022 Apr 28;52(2):125-138. doi: 10.4274/tjo.galenos.2021.24376.
9
Choroidal Melanoma Resection.脉络膜黑色素瘤切除术
Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):65-70. doi: 10.4103/meajo.MEAJO_73_18.
10
Prognostic factors of choroidal melanoma in Slovenia, 1986-2008.1986 - 2008年斯洛文尼亚脉络膜黑色素瘤的预后因素
Radiol Oncol. 2016 Feb 16;50(1):104-12. doi: 10.1515/raon-2015-0009. eCollection 2016 Mar 1.

本文引用的文献

4
Ten years experience with eye wall resection for uveal malignant melanomas.
Ophthalmology. 1984 Dec;91(12):1720-5. doi: 10.1016/s0161-6420(84)34086-6.
5
The local excision of choroidal melanomata.
Trans Ophthalmol Soc U K (1962). 1973;93(0):343-6.
6
Low-energy long-exposure laser therapy in the management of choroidal melanoma.
Graefes Arch Clin Exp Ophthalmol. 1986;224(1):26-31. doi: 10.1007/BF02144128.
8
Ciliary body tumours and their management.
Trans Ophthalmol Soc U K (1962). 1986;105 ( Pt 2):257-64.
9
Long-term results of proton beam irradiated uveal melanomas.
Ophthalmology. 1987 Apr;94(4):349-53. doi: 10.1016/s0161-6420(87)33456-6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验